2015
DOI: 10.1371/journal.pone.0141719
|View full text |Cite
|
Sign up to set email alerts
|

Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine

Abstract: Oral cancer is one of the main causes of cancer-related deaths in South-Asian countries. There are very limited treatment options available for oral cancer. Research endeavors focused on discovery and development of novel therapies for oral cancer, is necessary to control the ever rising oral cancer related mortalities. We mined the large pool of compounds from the publicly available compound databases, to identify potential therapeutic compounds for oral cancer. Over 84 million compounds were screened for the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
21
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(24 citation statements)
references
References 49 publications
(71 reference statements)
1
21
0
2
Order By: Relevance
“…There are many off‐target effects that the drugs utilized could have; hence an inducible system with upregulated Bax may be exploited in OSCC cell lines. Importantly, the present study lends credence to the inclusion of nimbolide as a natural compound with potential therapeutic efficacy against oral cancer, as well as a promising candidate agent for overcoming cisplatin resistance.…”
Section: Discussionsupporting
confidence: 56%
“…There are many off‐target effects that the drugs utilized could have; hence an inducible system with upregulated Bax may be exploited in OSCC cell lines. Importantly, the present study lends credence to the inclusion of nimbolide as a natural compound with potential therapeutic efficacy against oral cancer, as well as a promising candidate agent for overcoming cisplatin resistance.…”
Section: Discussionsupporting
confidence: 56%
“…The drug profile of 24 anticancer drugs was tested against a large number of cell lines in order to understand the relation between drug resistance and altered genomic features of a cancer cell line. Bundela et al (45) built an SVM-RBF model to identify potential therapeutic compounds for oral cancer from the large pool of compounds from the publicly available compound databases.…”
Section: Selecting Anticancer Drugs Warmuth Et Al (43) Used Activementioning
confidence: 99%
“…PT can penetrate the blood-brain barrier and reduce c-Met signaling in breast cancer cells, thereby promoting metastasis by inducing the secretion of the inflammatory cytokines IL8 and CXCL1, and can trigger vascular reprogramming by activating tumor-associated astrocytes to secrete the c-Met ligand HGF [22] . PT also represents a potential drug for treating other cancers, including ovarian cancer, prostate can- cer, oral cancer, and melanoma [23][24][25][26] . Here, we demonstrate the powerful cytotoxicity of PT on EC cells by triggering caspase-dependent apoptosis.…”
Section: Discussionmentioning
confidence: 99%